摘要: Die Vielzahl der Faktoren, die ein akutes Atemnotsyndrom des Erwachsenen auslosen konnen, und Komplexitat beteiligten Pathomechanismen erschweren Suche nach einem medikamentosen Therapieansatz, uber supportive Therapie hinausgreift. An 1. Stelle mus daher Behandlung Grunderkrankung, z.B. Behebung eines Schockzustandes, stehen. Ist dies nicht moglich, so kann potentiell Eingriff in den Ablauf zellularen humoralen weiteres Fortschreiten Erkrankung verhindern. Manifestationen Syndroms, wie pulmonale Hypertension Lungenodem, sind ebenfalls einer Pharmakotherapie zuganglich. Uber Beeinflusbarkeit Reparaturphase im Sinne Vorbeugung Vorbereitung Wiederherstellung geschadigten Organs ist bisher wenig bekannt.
springer.com
sci-hub.st 参考文章(48)
R B Zurier, P A Ward, J C Fantone, S L Kunkel, Suppression by prostaglandin E1 of vascular permeability induced by vasoactive inflammatory mediators. Journal of Immunology. ,vol. 125, pp. 2591- 2596 ,(1980)
J J Oppenheim, J T Hoffeld, Z Metzger, Regulation by PGE2 of the production of oxygen intermediates by LPS-activated macrophages. Journal of Immunology. ,vol. 127, pp. 1109- 1113 ,(1981)
John R. Fletcher, Billie Lou Short, Marilea K. Miller, Improved Survival in the Suckling Rat Model of Group B Streptococcal Sepsis After Treatment with Nonsteroidal Anti-inflammatory Drugs Pediatrics. ,vol. 70, pp. 343- 347 ,(1982)
DaleE Hammerschmidt, LeonardD Hudson, L.Jean Weaver, PhilipR Craddock, HarryS Jacob, ASSOCIATION OF COMPLEMENT ACTIVATION AND ELEVATED PLASMA-C5a WITH ADULT RESPIRATORY DISTRESS SYNDROME. Pathophysiological Relevance and Possible Prognostic Value The Lancet. ,vol. 315, pp. 947- 949 ,(1980) , 10.1016/S0140-6736(80)91403-8
J. Duchateau, Maurice Lamy, L. Radoux, I. Sprangers, M. Haas, F. X. Noel, M. Braun, H. Schreyen, Complement activation in patients at risk of developing the adult respiratory distress syndrome. The American review of respiratory disease. ,vol. 130, pp. 1058- 1064 ,(1984) , 10.1164/ARRD.1984.130.6.1058
N. N. Teng, C. M. Scudder, J. G. Jones, D. Royston, Thomas W Feeley, B. D. Minty, The effect of human antiendotoxin monoclonal antibodies on endotoxin-induced lung injury in the rat. The American review of respiratory disease. ,vol. 135, pp. 665- 670 ,(1987) , 10.1164/ARRD.1987.135.3.665
Douglas C. Brockmann, John H. Stevens, Peter O'Hanley, Jeffrey Shapiro, Clark Walker, Frederick G. Mihm, John A. Collins, Thomas A. Raffin, The effects of prostaglandin E1 on the adult respiratory distress syndrome in septic primates. The American review of respiratory disease. ,vol. 134, pp. 885- 890 ,(1986) , 10.1164/ARRD.1986.134.5.885
R M Tate, H G Morris, W R Schroeder, J E Repine, Oxygen metabolites stimulate thromboxane production and vasoconstriction in isolated saline-perfused rabbit lungs. Journal of Clinical Investigation. ,vol. 74, pp. 608- 613 ,(1984) , 10.1172/JCI111458
Kenneth L. Brigham, Ronald E. Bowers, Charles R. McKeen, Methylprednisolone Prevention of Increased Lung Vascular Permeability following Endotoxemia in Sheep Journal of Clinical Investigation. ,vol. 67, pp. 1103- 1110 ,(1981) , 10.1172/JCI110123
Jean E. Rinaldo, Mediation of ARDS by Leukocytes: Clinical Evidence and Implications for Therapy Chest. ,vol. 89, pp. 590- 593 ,(1986) , 10.1378/CHEST.89.4.590